Overview

Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis

Status:
Withdrawn
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This pilot trial studies how well a novel oral therapeutic agent performs to treat patients with atopic dermatitis, particularly facial dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Treatments:
Ivermectin